Point Mutation in the Stalk of Angiotensin-Converting Enzyme Causes a Dramatic Increase in Serum Angiotensin-Converting Enzyme But No Cardiovascular Disease

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation

• Publication date

  2001-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HC3601.095932PMID 11551873
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Shedding of Angiotensin-converting Enzyme by a Mutation Identified in the Stalk Region*

  2001cited by this paper
• Protein processing mechanisms: from angiotensin-converting enzyme to Alzheimer's disease.

  2000cited by this paper
• Specific Cellular Proteins Associate with Angiotensin-converting Enzyme and Regulate Its Intracellular Transport and Cleavage-Secretion*

  2000cited by this paper
• Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators.

  2000cited by this paper
• Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.

  2000cited by this paper
• Sequence variation in the human angiotensin converting enzyme

  1999cited by this paper
• Improved immunoradiometric assay for plasma renin.

  1999cited by this paper
• The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface.

  1998cited by this paper
• A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells

  1997cited by this paper
• Membrane protein secretases.

  1997cited by this paper
• The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular‐renal risk

  1997cited by this paper
• Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies

  1996cited by this paper
• A study of chimeras constructed with the two domains of angiotensin I-converting enzyme.

  1996cited by this paper
• Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence.

  1996cited by this paper
• Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme

  1995cited by this paper
• Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site.

  1994cited by this paper
• Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes.

  1993cited by this paper
• Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site.

  1993cited by this paper
• Regional angiotensin II production in essential hypertension and renal artery stenosis.

  1993cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

  1992cited by this paper
• Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids.

  1991cited by this paper
• Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.

  1991cited by this paper
• Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes.

  1991cited by this paper
• Familial elevation of serum angiotensin converting enzyme activity.

  1990cited by this paper
• Metabolism and Production of Angiotensin I in Different Vascular Beds in Subjects With Hypertension

  1990cited by this paper
• Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats.

  1990cited by this paper
• An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

  1990cited by this paper
• Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

  1988cited by this paper
• Familial elevation of serum angiotensin converting enzyme.

  1985cited by this paper
• Easy calculations of lod scores and genetic risks on small computers.

  1984cited by this paper
• Angiotensin‐Converting Enzyme in Cultured Endothelial Cells: Synthesis, Degradation, and Transfer to Culture Medium

  1983cited by this paper
• Colorimetry of angiotensin-I converting enzyme activity in serum.

  1981cited by this paper
• A sensitive fluorimetric assay for serum angiotensin-converting enzyme.

  1976cited by this paper
• Studies on the angiotensin converting enzyme with different substrates.

  1970cited by this paper

• Further Development of SAMPDI-3D: A Machine Learning Method for Predicting Binding Free Energy Changes Caused by Mutations in Either Protein or DNA

  2025cites this paper
• Pharmacogenomics Informs Cardiovascular Pharmacotherapy.

  2022cites this paper
• Predictive potential of ACE phenotyping in extrapulmonary sarcoidosis

  2022cites this paper
• ACE High: When It's Not a Winner for Diagnosis of Sarcoidosis.

  2020cites this paper
• Novel ACE mutations mimicking sarcoidosis by increasing blood ACE levels.

  2020cites this paper
• Focus on increased serum angiotensin-converting enzyme level: From granulomatous diseases to genetic mutations.

  2018cites this paper
• Humanization of Murine Monoclonal anti-hTNF Antibody: The F10 Story

  2017cites this paper
• ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors

  2017cites this paper
• Conformational Fingerprinting Using Monoclonal Antibodies (on the Example of Angiotensin I-Converting Enzyme-ACE)

  2017cites this paper
• Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding

  2016cites this paper
• The effect of structural motifs on the ectodomain shedding of human angiotensin-converting enzyme.

  2016cites this paper
• A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation

  2015influential citation
• A Novel Angiotensin I-Converting Enzyme Mutation (S333W) Impairs N-Domain Enzymatic Cleavage of the Anti-Fibrotic Peptide, AcSDKP

  2014cites this paper
• Developments in renal pharmacogenomics and applications in chronic kidney disease

  2014cites this paper
• New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) III: Endogenous Inhibition of Angiotensin Converting Enzyme (ACE) Provides Protection against Cardiovascular Diseases

  2014cites this paper
• New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition

  2014cites this paper
• Extreme elevation of serum angiotensin-converting enzyme (ACE) activity: always consider familial ACE hyperactivity

  2014influential citation
• Multi-Species Comparative Analysis of the Equine ACE Gene Identifies a Highly Conserved Potential Transcription Factor Binding Site in Intron 16

  2013cites this paper
• A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme

  2013cites this paper
• A Novel Splice-Site Mutation in Angiotensin I-Converting Enzyme (ACE) Gene, c.3691+1G>A (IVS25+1G>A), Causes a Dramatic Increase in Circulating ACE through Deletion of the Transmembrane Anchor

  2013influential citation
• Peptidyl-Dipeptidase A/Angiotensin I-Converting Enzyme

  2013cites this paper
• Role of Genetic Factors in the Development of Congestive Heart Failure

  2013cites this paper
• Angiotensin-Converting Enzyme Gene Polymorphisms in Patients with Pulmonary Sarcoidosis

  2012cites this paper
• Protein-protein interactions of human somatic angiotensin-converting enzyme

  2011cites this paper
• Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety

  2011cites this paper
• An Angiotensin I-Converting Enzyme Mutation (Y465D) Causes a Dramatic Increase in Blood ACE via Accelerated ACE Shedding

  2011influential citation
• Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine

  2011cites this paper
• Angiotensin-converting enzyme 2 ectodomain shedding cleavage-site identification: determinants and constraints.

  2011cites this paper
• Prognostic value of serum angiotensin-converting enzyme activity for outcome of community-acquired pneumonia

  2011cites this paper
• Angiotensin I-Converting Enzyme Mutation (Trp1197Stop) Causes a Dramatic Increase in Blood ACE

  2009cites this paper
• Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype

  2008cites this paper
• Genetics of the human renin angiotensin system

  2008cites this paper
• Adaptation to High Altitude in Sherpas: Association with the Insertion/Deletion Polymorphism in the Angiotensin-Converting Enzyme Gene

  2008cites this paper
• Unraveling the Complexities of the Renin-Angiotensin System: From ACE to renin inhibition

  2008cites this paper
• ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?

  2007cites this paper
• Signaling via the Angiotensin-Converting Enzyme Results in the Phosphorylation of the Nonmuscle Myosin Heavy Chain IIA

  2006cites this paper
• Hereditary hyper-ACE-emia due to the Pro1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family outside Europe

  2006cites this paper
• Detection of mutated angiotensin I-converting enzyme by serum/plasma analysis using a pair of monoclonal antibodies.

  2005cites this paper
• Monoclonal Antibodies 1B3 and 5C8 as Probes for Monitoring the Integrity of the C-Terminal End of Soluble Angiotensin-Converting Enzyme

  2005cites this paper
• Polimorfismo G-699C en la región promotora del receptor B1 de bradikinina y tos inducida por enalapril

  2005cites this paper
• Localization of an N-domain region of angiotensin-converting enzyme involved in the regulation of ectodomain shedding using monoclonal antibodies.

  2005cites this paper
• And Characterization, Should Hasten Our Understanding of Detection of Mutated Angiotensin I-converting En- Zyme by Serum/plasma Analysis Using a Pair of Mono

  2005cites this paper
• Use of low concentrations of human IgA anti-tissue transglutaminase to rule out selective IgA deficiency in patients with suspected celiac disease.

  2005cites this paper
• Secretase-mediated cell surface shedding of the angiotensin-converting enzyme.

  2004cites this paper
• Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects.

  2004cites this paper
• The ACE (I/D) polymorphism and the RAAS in type 1 diabetes mellitus

  2004cites this paper
• Hereditary elevation of angiotensin converting enzyme suggesting neurosarcoidosis

  2003cites this paper
• Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells.

  2003cites this paper
• Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease--pathophysiological considerations.

  2003cites this paper
• Peripheral nerve disease in SARS:

  2003cites this paper
• ACE genotype and ACE inhibitor response in kidney disease: a perspective.

  2002cites this paper
• Epitope-specific antibody-induced cleavage of angiotensin-converting enzyme from the cell surface.

  2002cites this paper
• Grossly elevated serum angiotensin-converting enzyme activities are still suppressible with ACE inhibitor therapy

  2002cites this paper